Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Degeneration | 5 | 2020 | 415 | 1.210 |
Why?
|
| Retinal Ganglion Cells | 12 | 2023 | 770 | 1.010 |
Why?
|
| Retinal Diseases | 4 | 2023 | 685 | 0.870 |
Why?
|
| Nerve Regeneration | 8 | 2022 | 788 | 0.820 |
Why?
|
| Retina | 9 | 2023 | 2612 | 0.800 |
Why?
|
| Optic Nerve | 8 | 2022 | 554 | 0.750 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2023 | 705 | 0.700 |
Why?
|
| Contrast Sensitivity | 2 | 2019 | 242 | 0.670 |
Why?
|
| Rhodopsin | 1 | 2019 | 203 | 0.660 |
Why?
|
| Microglia | 3 | 2023 | 1267 | 0.630 |
Why?
|
| Glaucoma | 3 | 2023 | 1158 | 0.520 |
Why?
|
| Stem Cells | 6 | 2020 | 3566 | 0.460 |
Why?
|
| Vision Disorders | 1 | 2019 | 1055 | 0.420 |
Why?
|
| Optic Nerve Injuries | 4 | 2012 | 150 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2013 | 1434 | 0.380 |
Why?
|
| Axons | 6 | 2022 | 1685 | 0.320 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 1620 | 0.300 |
Why?
|
| Ephrin-A3 | 2 | 2014 | 6 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 4 | 2020 | 2692 | 0.200 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 2 | 2023 | 216 | 0.200 |
Why?
|
| Optic Nerve Diseases | 2 | 2016 | 327 | 0.180 |
Why?
|
| Ocular Hypertension | 2 | 2012 | 198 | 0.180 |
Why?
|
| Goblet Cells | 1 | 2022 | 287 | 0.180 |
Why?
|
| Tauopathies | 1 | 2023 | 307 | 0.170 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2012 | 136 | 0.170 |
Why?
|
| Oligodendroglia | 1 | 2022 | 517 | 0.160 |
Why?
|
| Myelin Sheath | 1 | 2022 | 652 | 0.160 |
Why?
|
| 2-Aminoadipic Acid | 2 | 2008 | 33 | 0.160 |
Why?
|
| Dry Eye Syndromes | 1 | 2022 | 386 | 0.160 |
Why?
|
| Electroretinography | 1 | 2019 | 509 | 0.150 |
Why?
|
| Retinal Vessels | 2 | 2020 | 772 | 0.150 |
Why?
|
| Central Nervous System | 1 | 2005 | 1358 | 0.150 |
Why?
|
| Intraocular Pressure | 3 | 2012 | 1269 | 0.150 |
Why?
|
| Calcium Signaling | 2 | 2020 | 721 | 0.140 |
Why?
|
| Mice | 21 | 2023 | 81154 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2016 | 23398 | 0.140 |
Why?
|
| Animals | 27 | 2023 | 168660 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 21824 | 0.130 |
Why?
|
| Vimentin | 2 | 2007 | 262 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2007 | 528 | 0.120 |
Why?
|
| Ephrin-A2 | 1 | 2014 | 25 | 0.120 |
Why?
|
| Myelin Proteins | 2 | 2005 | 215 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 1962 | 0.120 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 18027 | 0.120 |
Why?
|
| Vision, Ocular | 1 | 2016 | 457 | 0.110 |
Why?
|
| Visual Fields | 1 | 2019 | 1041 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2013 | 2725 | 0.110 |
Why?
|
| Muscarinic Agonists | 1 | 2012 | 87 | 0.100 |
Why?
|
| Neuroglia | 2 | 2008 | 928 | 0.100 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2012 | 94 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2023 | 2850 | 0.100 |
Why?
|
| Microspheres | 2 | 2012 | 777 | 0.100 |
Why?
|
| Models, Anatomic | 2 | 2005 | 690 | 0.100 |
Why?
|
| Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14563 | 0.100 |
Why?
|
| Cell Differentiation | 5 | 2020 | 11478 | 0.100 |
Why?
|
| Electric Stimulation Therapy | 1 | 2016 | 605 | 0.090 |
Why?
|
| Globins | 1 | 2011 | 416 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 2134 | 0.090 |
Why?
|
| Visual Acuity | 1 | 2018 | 2525 | 0.090 |
Why?
|
| Astrocytes | 2 | 2008 | 1273 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 9731 | 0.080 |
Why?
|
| Gliosis | 2 | 2007 | 245 | 0.080 |
Why?
|
| Lithium Carbonate | 1 | 2008 | 184 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.070 |
Why?
|
| Electric Stimulation | 2 | 2022 | 1760 | 0.070 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 152 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 449 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4749 | 0.070 |
Why?
|
| Tomography, Optical Coherence | 2 | 2015 | 2657 | 0.060 |
Why?
|
| Epitopes | 1 | 2012 | 2570 | 0.060 |
Why?
|
| Receptor, EphA4 | 2 | 2014 | 18 | 0.060 |
Why?
|
| Cells, Cultured | 6 | 2020 | 19232 | 0.060 |
Why?
|
| Retinal Detachment | 1 | 2007 | 411 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 712 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2047 | 0.050 |
Why?
|
| Fluorescein | 1 | 2022 | 171 | 0.050 |
Why?
|
| Homeostasis | 2 | 2023 | 3337 | 0.050 |
Why?
|
| Tears | 1 | 2022 | 256 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 1008 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 12066 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2005 | 1342 | 0.050 |
Why?
|
| Visual Pathways | 1 | 2005 | 558 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2007 | 5179 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2891 | 0.050 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2015 | 204 | 0.050 |
Why?
|
| Conjunctiva | 1 | 2022 | 494 | 0.040 |
Why?
|
| Axotomy | 2 | 2012 | 73 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 2020 | 240 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4463 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8939 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2018 | 331 | 0.040 |
Why?
|
| Tubulin | 2 | 2012 | 695 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 844 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3000 | 0.040 |
Why?
|
| Head Movements | 1 | 2018 | 149 | 0.040 |
Why?
|
| Neurites | 2 | 2012 | 388 | 0.040 |
Why?
|
| Rats | 4 | 2018 | 24250 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2008 | 429 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2018 | 2110 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 986 | 0.030 |
Why?
|
| Nerve Crush | 2 | 2005 | 78 | 0.030 |
Why?
|
| Eye Movements | 1 | 2018 | 500 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10477 | 0.030 |
Why?
|
| Eye Diseases | 1 | 2020 | 668 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 743811 | 0.030 |
Why?
|
| Pilocarpine | 1 | 2012 | 63 | 0.030 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2012 | 32 | 0.030 |
Why?
|
| Timolol | 1 | 2012 | 52 | 0.030 |
Why?
|
| Thiazines | 1 | 2012 | 38 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 175 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Carbohydrate Conformation | 1 | 2012 | 209 | 0.030 |
Why?
|
| Transcription Factor CHOP | 1 | 2012 | 73 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 2012 | 161 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 2013 | 244 | 0.030 |
Why?
|
| Chondroitin Sulfates | 1 | 2012 | 187 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2018 | 2019 | 0.030 |
Why?
|
| Growth Cones | 1 | 2012 | 117 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 253 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4221 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2011 | 112 | 0.020 |
Why?
|
| Superoxides | 1 | 2011 | 387 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 505 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2012 | 289 | 0.020 |
Why?
|
| Anterior Chamber | 1 | 2011 | 197 | 0.020 |
Why?
|
| Rabbits | 1 | 2016 | 4894 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2013 | 308 | 0.020 |
Why?
|
| Tonometry, Ocular | 1 | 2011 | 237 | 0.020 |
Why?
|
| Chickens | 1 | 2012 | 864 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 2017 | 0.020 |
Why?
|
| Visual Perception | 1 | 2018 | 1414 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 758 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2012 | 519 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2503 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 1472 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 3645 | 0.020 |
Why?
|
| Recoverin | 1 | 2008 | 13 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 840 | 0.020 |
Why?
|
| Research | 1 | 2016 | 1999 | 0.020 |
Why?
|
| Mitochondrial Diseases | 1 | 2011 | 320 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 839 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2008 | 322 | 0.020 |
Why?
|
| beta Catenin | 1 | 2013 | 1060 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1142 | 0.020 |
Why?
|
| Brain | 2 | 2023 | 26345 | 0.020 |
Why?
|
| Dependovirus | 1 | 2012 | 705 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1374 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2020 | 12209 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4033 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1705 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2086 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 644 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2005 | 67 | 0.020 |
Why?
|
| Amino Acids | 1 | 2012 | 1733 | 0.020 |
Why?
|
| Neurons | 1 | 2005 | 9336 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9377 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 620 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 575 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 623 | 0.020 |
Why?
|
| Prevalence | 1 | 2021 | 15211 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2005 | 435 | 0.020 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2004 | 77 | 0.020 |
Why?
|
| Peroneal Nerve | 1 | 2004 | 74 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 2077 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10629 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13273 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2012 | 1938 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2008 | 1168 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5078 | 0.010 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 1978 | 0.010 |
Why?
|
| Transplants | 1 | 2004 | 209 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5881 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5973 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8300 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2011 | 3082 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2475 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3874 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 1794 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2008 | 2963 | 0.010 |
Why?
|
| Quinazolines | 1 | 2005 | 1356 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 2593 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 13028 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2865 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18355 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 2459 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 9272 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 3794 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 5021 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9648 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77410 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 5755 | 0.010 |
Why?
|
| Male | 2 | 2007 | 349776 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40038 | 0.010 |
Why?
|
| Female | 1 | 2005 | 380020 | 0.000 |
Why?
|
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_